MedTrace Logo

Insulin-sensitive Obesity: Lessons From Longitudinal Data

NCT02017210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2020-02-24

Study results available
· View outcomes & findings →

Summary

People who are overweight and/or obese are at risk of insulin resistance and type 2 diabetes. However, research has shown that some overweight and/or obese individuals remain insulin-sensitive and metabolically healthy despite their unhealthy body weight.

The investigators hypothesise that overweight and/or obese people who were deemed insulin-sensitive in previous studies will maintain their insulin sensitivity and metabolic health over time. The investigators also hypothesise that the preservation of insulin sensitivity will be accompanied by key metabolic health markers.

Conditions

  • Insulin Sensitivity/Resistance
  • Obesity

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER

  • Life for a Child Program, Diabetes Australia

    collaborator OTHER

  • The University of New South Wales

    collaborator OTHER

  • University of Sydney

    collaborator OTHER

  • St Vincent's Hospital, Sydney

    collaborator OTHER

  • Garvan Institute of Medical Research

    lead OTHER

Principal Investigators

  • Jerry R Greenfield, MBBS, PhD · Garvan Institute of Medical Research

  • Dorit Samocha-Bonet, MSc, PhD · Garvan Institute of Medical Research

Eligibility

Min Age
26 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017210 on ClinicalTrials.gov